© 2022 MJH Life Sciences and AJMC - Managed Care News, Research, and Expert Insights. All rights reserved.
© 2022 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
Jared is a freelance writer for The American Journal of Managed Care® (AJMC®), and previously worked as a senior editor for HCPLive® at MJH Life Sciences®.
He has an MA from University of Sioux Falls. You can connect with Jared on LinkedIn.
September 26, 2022
Only about 11% of patients received care meeting a composite quality metric, a study found.
September 25, 2022
The patient was successfully treated with rituximab and intravenous immunoglobulin.
However, patient-reported scores were not significantly better in the tocilizumab group.
September 21, 2022
A new study looks at the balancing act physicians and families must carry out when managing expectations at a time of great scientific advancement in spinal muscular atrophy (SMA) and Duchenne muscular dystrophy (DMD).
September 20, 2022
At 12 weeks, nearly 8 in 10 patients had significant improvement.
September 19, 2022
The case involved a 69-year-old man who presented with lupus nephritis.
September 15, 2022
A new review article explains the role of biologics in treatment systemic lupus erythematosus (SLE) and lupus nephritis.
September 13, 2022
New data show litifilimab outperformed placebo in patients with active arthritis and skin manifestations due to systemic lupus erythematosus (SLE).
September 12, 2022
About 4 in 10 patients do not receive curative therapy despite early detection, a new study shows.
A study carried out at 4 health care systems found rates of stage I lung cancer increased, and rates of stage IV cancer decreased, once screening was initiated.